February 3, 2014—The Department of Health and Human Services Office of Inspector General (OIG) plans to issue three important studies about the 340B program by this fall on contract pharmacy, overcharging by drug manufacturers, and passing savings along to Medicare.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)